- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Mirion Technologies Inc (MIR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/30/2025: MIR (5-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $30.62
1 Year Target Price $30.62
| 3 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 61.46% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.81B USD | Price to earnings Ratio 216.09 | 1Y Target Price 30.62 |
Price to earnings Ratio 216.09 | 1Y Target Price 30.62 | ||
Volume (30-day avg) 5 | Beta 0.94 | 52 Weeks Range 12.00 - 30.28 | Updated Date 12/30/2025 |
52 Weeks Range 12.00 - 30.28 | Updated Date 12/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.94% | Operating Margin (TTM) 3.77% |
Management Effectiveness
Return on Assets (TTM) 1.18% | Return on Equity (TTM) 1.61% |
Valuation
Trailing PE 216.09 | Forward PE - | Enterprise Value 6241170910 | Price to Sales(TTM) 6.44 |
Enterprise Value 6241170910 | Price to Sales(TTM) 6.44 | ||
Enterprise Value to Revenue 6.92 | Enterprise Value to EBITDA 29.91 | Shares Outstanding 244370206 | Shares Floating 211703424 |
Shares Outstanding 244370206 | Shares Floating 211703424 | ||
Percent Insiders 3.72 | Percent Institutions 105.76 |
Upturn AI SWOT
Mirion Technologies Inc
Company Overview
History and Background
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, and control solutions. The company was formed through the merger of Mirion Technologies and Hologic's Health and Medical Technologies Division, creating a combined entity focused on serving critical markets. Its roots trace back to various acquisitions and integrations of established radiation detection companies, solidifying its expertise in nuclear, medical, and defense sectors. A significant milestone was its public listing via a SPAC merger with GS Acquisition Holdings Corp. II in 2021.
Core Business Areas
- Detection & Measurement: This segment encompasses a broad range of radiation detection instruments, including Geiger-Mu00fcller tubes, scintillation detectors, and specialized sensors. These products are used in applications ranging from environmental monitoring and industrial safety to nuclear power plant operations and homeland security.
- Integrated Solutions: Mirion offers integrated systems and services that combine hardware, software, and expertise for complex radiation management. This includes solutions for personnel dosimetry, area monitoring, and waste management in nuclear facilities, as well as diagnostic imaging equipment for the medical industry.
- Medical: This area focuses on providing advanced imaging and radiation therapy solutions for the healthcare sector. Products may include components for medical imaging equipment and systems designed to improve patient outcomes in radiation oncology.
Leadership and Structure
Mirion Technologies operates under a CEO and a Board of Directors. The executive leadership team is responsible for strategic direction and operational management. The company is structured into business units that align with its core market segments to ensure specialized focus and expertise.
Top Products and Market Share
Key Offerings
- Description: High-performance radiation detectors and systems for a wide range of applications, including nuclear physics research, homeland security, and environmental monitoring. Competitors include Thermo Fisher Scientific (through its various brands), ORTEC (also part of AMETEK), and Ludlum Measurements.
- Market Share Data: Specific market share data for individual product lines is not publicly disclosed but the company is a significant player in the specialized radiation detection market.
- Product Name 1: Canberra Detectors
- Description: Real-time dosimetry solutions for radiation workers, offering enhanced safety and compliance. Competitors include Landauer, Inc., and other providers of radiation monitoring services. Market share is not publicly detailed but is a key offering in the personnel dosimetry market.
- Market Share Data: Information not publicly disclosed.
- Product Name 2: DoseTrace
- Description: Integrated radiation monitoring systems for nuclear power plants and research facilities. Competitors include AE Technologies, Studsvik, and various engineering and safety consultancies. Market share is not publicly detailed but it is a critical offering for nuclear safety.
- Market Share Data: Information not publicly disclosed.
- Product Name 3: SpectraVision
Market Dynamics
Industry Overview
Mirion Technologies operates in the radiation detection, measurement, and control industry, which is driven by stringent safety regulations, technological advancements, and critical applications in nuclear energy, healthcare, defense, and research. The market is characterized by a need for high-reliability, precision, and compliance with international standards. Growth is influenced by global investments in nuclear power, advancements in medical imaging and therapy, and increasing security concerns.
Positioning
Mirion Technologies is positioned as a leading global provider of integrated solutions for radiation management. Its competitive advantages stem from its comprehensive product portfolio, deep technical expertise, long-standing customer relationships in highly regulated industries, and a diversified market presence. The company benefits from its ability to offer end-to-end solutions, from individual sensor components to complex integrated systems.
Total Addressable Market (TAM)
The total addressable market for radiation detection, measurement, and control solutions is substantial and growing, encompassing global markets for nuclear energy, medical devices, security, and scientific research. Analysts estimate this market to be in the tens of billions of dollars. Mirion Technologies is strategically positioned to capture a significant portion of this TAM through its diverse product offerings and its established presence in key sectors.
Upturn SWOT Analysis
Strengths
- Broad and diversified product portfolio
- Strong technical expertise and intellectual property
- Established customer relationships in critical industries (nuclear, medical)
- Global presence and distribution network
- History of strategic acquisitions to expand capabilities
Weaknesses
- Dependence on cyclical industries (e.g., nuclear power construction)
- Integration challenges from past acquisitions
- Competition from larger, more diversified conglomerates
- Relatively recent public company status, needing to build investor familiarity
Opportunities
- Growing demand for advanced medical imaging and radiation therapy
- Increased focus on nuclear safety and security globally
- Expansion into emerging markets
- Development of new sensor technologies and digital solutions
- Potential for further strategic acquisitions
Threats
- Geopolitical instability impacting nuclear energy projects
- Changes in regulatory environments
- Technological disruption from competitors
- Economic downturns affecting capital expenditure in key industries
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Thermo Fisher Scientific (TMO)
- AMETEK, Inc. (AME)
- GE HealthCare Technologies Inc. (GEHC)
Competitive Landscape
Mirion Technologies competes with larger, diversified companies like Thermo Fisher Scientific and AMETEK, as well as specialized medical imaging providers like GE HealthCare. Mirion's advantage lies in its specialized focus and deep expertise in radiation detection and measurement across multiple critical industries, allowing for tailored solutions. However, larger competitors may have greater financial resources and broader market reach.
Major Acquisitions
Hologic's Health and Medical Technologies Division
- Year: 2021
- Acquisition Price (USD millions): Not explicitly disclosed as part of the SPAC merger, but represented a significant portion of the combined entity's valuation.
- Strategic Rationale: To create a leading global entity in radiation detection, measurement, and control, with expanded capabilities in medical imaging and healthcare.
Growth Trajectory and Initiatives
Historical Growth: Mirion Technologies has demonstrated growth through a combination of organic expansion within its core markets and strategic acquisitions that have broadened its technology base and market reach. The company's history is marked by consolidating key players in the radiation detection and measurement space.
Future Projections: Future growth is projected to be driven by increasing demand for radiation safety and measurement in nuclear energy, healthcare advancements, and evolving security needs. Analyst estimates will vary, but generally anticipate continued revenue growth, potentially accelerated by further strategic partnerships and acquisitions.
Recent Initiatives: Recent initiatives likely include the integration of acquired businesses, expansion of its product offerings into new applications, and investment in digital technologies to enhance its data analytics and service capabilities. The company also focuses on maintaining strong regulatory compliance and customer service in its specialized markets.
Summary
Mirion Technologies is a well-established leader in the radiation detection and measurement sector, benefiting from its diversified product portfolio and strong presence in critical industries like nuclear energy and healthcare. Its history of strategic acquisitions has solidified its market position. While facing competition from larger players and cyclical industry influences, the company's expertise and focus on safety and medical applications provide a solid foundation for future growth. Continued investment in innovation and market expansion will be key to its ongoing success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations
- SEC Filings (10-K, 10-Q)
- Financial News Outlets (e.g., Bloomberg, Reuters)
- Market Research Reports
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. The data presented is based on publicly available information and may not be exhaustive or perfectly up-to-date. Specific market share percentages are estimates based on industry analysis. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Chairman Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2860 | Website https://www.mirion.com |
Full time employees 2860 | Website https://www.mirion.com | ||
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

